These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15541581)

  • 21. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
    Glimelius B; Dahl O; Cedermark B; Jakobsen A; Bentzen SM; Starkhammar H; Grönberg H; Hultborn R; Albertsson M; Påhlman L; Tveit KM;
    Acta Oncol; 2005; 44(8):904-12. PubMed ID: 16332600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
    Al-Batran SE; Hartmann JT; Probst S; Schmalenberg H; Hollerbach S; Hofheinz R; Rethwisch V; Seipelt G; Homann N; Wilhelm G; Schuch G; Stoehlmacher J; Derigs HG; Hegewisch-Becker S; Grossmann J; Pauligk C; Atmaca A; Bokemeyer C; Knuth A; Jäger E;
    J Clin Oncol; 2008 Mar; 26(9):1435-42. PubMed ID: 18349393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
    J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity and toxicity of oxaliplatin and bolus fluorouracil plus leucovorin in pretreated colorectal cancer patients: a phase II study.
    Ferraresi V; Giampaolo MA; Gabriele A; Mansueto G; Buccilli A; Giannarelli D; Ciccarese M; Gamucci T
    J Exp Clin Cancer Res; 2005 Jun; 24(2):187-96. PubMed ID: 16110750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
    J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
    Grothey A; Sargent DJ
    J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
    [No Abstract]   [Full Text] [Related]  

  • 29. Adjuvant chemotherapy for colon cancer: evidence on improvement in survival.
    Samantas E; Dervenis C; Rigatos SK
    Dig Dis; 2007; 25(1):67-75. PubMed ID: 17384510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy of stage III colon cancer.
    Benson AB
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S74-7. PubMed ID: 16399437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy with cisplatin, etoposide, fluorouracil and leucovorin for gastric carcinoma.
    Papadakou M; Xydakis E; Bonios M; Makropoulou E; Boukis C; Kakavoulis T; Karaliotas C; Panagos G
    J BUON; 2006; 11(3):285-9. PubMed ID: 17309151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laparoscopically assisted colectomy is as safe and effective as open colectomy in people with colon cancer Abstracted from: Nelson H, Sargent D, Wieand HS, et al; for the Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004; 350: 2050-2059.
    Cancer Treat Rev; 2004 Dec; 30(8):707-9. PubMed ID: 15541580
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant treatment of colorectal cancer.
    Carrato A
    Gastrointest Cancer Res; 2008 Jul; 2(4 Suppl):S42-6. PubMed ID: 19343149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing Trial and Real-world Adjuvant Oxaliplatin Delivery in Patients With Stage III Colon Cancer Using a Longitudinal Cumulative Dose.
    Webster-Clark M; Keil AP; Robert N; Frytak JR; Boyd M; Stürmer T; Sanoff H; Westreich D; Lund JL
    JAMA Oncol; 2022 Oct; 8(12):1821-4. PubMed ID: 36227604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada.
    Attard CL; Maroun JA; Alloul K; Grima DT; Bernard LM
    Curr Oncol; 2010 Feb; 17(1):17-24. PubMed ID: 20179799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.
    Marshall JL; Haller DG; de Gramont A; Hochster HS; Lenz HJ; Ajani JA; Goldberg RM
    Gastrointest Cancer Res; 2007 Jul; 1(4):146-54. PubMed ID: 19262703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expressions of 10 genes as candidate predictors of recurrence in stage III colon cancer patients receiving adjuvant oxaliplatin-based chemotherapy.
    Kumamoto K; Nakachi Y; Mizuno Y; Yokoyama M; Ishibashi K; Kosugi C; Koda K; Kobayashi M; Tanakaya K; Matsunami T; Eguchi H; Okazaki Y; Ishida H
    Oncol Lett; 2019 Aug; 18(2):1388-1394. PubMed ID: 31423202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type B lactic acidosis from fluorouracil in fluorouracil, oxaliplatin and leucovorin treatment for carcinoma of the colon in a hemodialysis patient.
    Yeung EK; Copland MA; Gill S
    Clin Kidney J; 2018 Dec; 11(6):786-787. PubMed ID: 30524712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reply to the Letter to the Editor "Defining the Optimal Regimen for Stage III Colon Cancer: Concerns With Study Design" by Guven DC et al.
    Sunami E; Sugihara K
    Clin Colorectal Cancer; 2020 Sep; 19(3):e73-e74. PubMed ID: 32646654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.